bit.bio appoints new Chief Financial Officer, Przemek Obloj
31.07.2024bit.bio appoints new Chief Financial Officer, Przemek Obloj
bit.bio appoints new Chief Financial Officer, Przemek Obloj
31.07.2024bit.bio appoints new Chief Financial Officer, Przemek Obloj
bit.bio launches panel of 16 neurodegenerative disease models for research and drug discovery in Alzheimer’s and Parkinson’s disea...
24.07.2024bit.bio launches ioAstrocytes, advancing how scientists can model the human brain.
20.06.2024Bi/ond and bit.bio collaboration offers a significant advancement for DMD research and drug discovery.
30.04.2024bit.bio will participate in an engaging fireside chat at SynBioBeta 2024 featuring Nobel Laureate Thomas Südhof and bit.bio Founde...
29.04.2024bit.bio selected to join the ‘Future Fifty’ 2024 cohort as one of the UK’s most exciting technology companies.
19.03.2024bit.bio announce first project in multi-year collaboration agreement with The Michael J. Fox Foundation to generate products for r...
05.03.2024Ginkgo Technology Network brings together over 25 partners across an array of capabilities including AI, genetic medicines, biolog...
28.02.2024Team will present posters including 2 on ioCRISPR-Ready Cells & host an expert panel discussion on the important role of functiona...
30.01.2024